戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                          We also found novel somatoform and antagonism dimensions, which this investi
2               Present evidence suggests that somatoform and factitious disorders are over-represented
3 e study of the characteristics of women with somatoform and factitious disorders who involve their ch
4 s is the first study to include a variety of somatoform and personality disorders.
5 ts assigned ozanimod 0.5 mg: optic neuritis, somatoform autonomic dysfunction, and cervical squamous
6 ith less dramatic features, fewer additional somatoform complaints, and lower dissociation scores.
7 d disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.
8 nd Statistical Manual of Mental Disorders-IV somatoform diagnoses.
9 line personality disorder (factors 3 and 4), somatoform disorder (factors 1 and 2), paranoid and depe
10 he basis of DSM-IV criteria and absence of a somatoform disorder and a plausible medical explanation.
11 ive, while the criteria for undifferentiated somatoform disorder are overly inclusive.
12 patients, however, no conclusive features of somatoform disorder or psychogenic disorder can be found
13 iodemographic characteristics, patients with somatoform disorder still had more primary care visits (
14 m posttraumatic stress disorder, depression, somatoform disorder, and malingering.
15 han the DSM-IV diagnosis of undifferentiated somatoform disorder.
16 t many patients fulfil strict criteria for a somatoform disorder/psychogenic dystonia.
17 ommon current psychiatric diagnoses included somatoform disorders (89%), dissociative disorders (91%)
18 stent with advancing research on anxiety and somatoform disorders and offers greater insights into th
19                                              Somatoform disorders are an important determinant of med
20                                              Somatoform disorders in pediatric care are associated wi
21                              Only 3 cases of somatoform disorders were identified, and all were assoc
22 improve both the reliability and validity of somatoform disorders will be a major challenge.
23 osis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (cluster B and par
24 m disorders, substance abuse, and anxiety or somatoform disorders).
25  mood disorders, neurotic stress-related and somatoform disorders, and a range of developmental and c
26 t nonepileptic seizures are in a spectrum of somatoform disorders, diagnostic literature is reviewed
27 ology and maintenance of somatic disease and somatoform disorders, is an important factor in the beha
28 the diagnoses subsumed under the category of somatoform disorders, various nosological questions are
29 nd sensory symptoms, functional seizures and somatoform disorders.
30 h as sleep disorder, depression, anxiety and somatoform disorders.
31 nt a structured assessment of depressive and somatoform disorders.
32 ood disorders; neurotic, stress-related, and somatoform disorders; eating disorders; specific persona
33 her anxiety disorders, eating disorders, and somatoform disorders; higher scores on most subscales of
34  psychotic, posttraumatic stress or anxiety, somatoform, neurocognitive, and eating disorders, as wel
35 order (psychosis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (clust
36 ealth Questionnaire-15 and the Screening for Somatoform Symptoms Conversion Disorder subscale.
37 umber of physical symptoms and the number of somatoform symptoms correlated with difficulty (r = 0.39
38 s and physician-assessed psychopathology and somatoform symptoms were evaluated by using the PRIME-MD
39 ve Experiences Scale, and Screening Test for Somatoform Symptoms) a mean of 11.9 years after manifest

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。